Table 5. Incidence of adverse events during the study period.
| Adverse event | HPTC group (n = 40) | dHACM group (n = 40) |
| Mild erythema | Two patients (5.0%) | Four patients (10.0%) |
| Mild allergic reaction | None (0%) | Two patients (5.0%) |
| Major events | None (0%) | None (0%) |
| Total | Two patients (5.0%) | Six patients (15.0%) |